Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Elexacaftor-Tezacaftor-Ivacaftor (ETI) improve stomach, gullet, nose and throat symptoms in people with advanced CF

Elexacaftor-Tezacaftor-Ivacaftor (ETI) improve stomach, gullet, nose and throat symptoms in people with advanced CF

Resource Type

CF Research News

Authors

Sufyan Shakir, Carlos Echevarria, Simon Doe, Malcolm Brodlie, Christopher Ward, Stephen J Bourke

References

J Cyst Fibros. 2022 Jun 16;S1569-1993(22)00591-4. doi: 10.1016/j.jcf.2022.06.003.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Nutrition/Gastroenterology [4]

Keywords

CFTR modulators [5]
Gastro-oesophageal reflux [6]
Sinonasal symptoms [7]

Date

Thursday, June 16, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/elexacaftor-tezacaftor-ivacaftor-eti-improve-stomach-gullet-nose

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00515R2_FINAL_Bourke_100722.pdf [2] https://pubmed.ncbi.nlm.nih.gov/35718668/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/nutritiongatroenterology [5] https://www.ecfs.eu/research-article-keywords/cftr-modulators [6] https://www.ecfs.eu/research-article-keywords/gastro-oesophageal-reflux [7] https://www.ecfs.eu/research-article-keywords/sinonasal-symptoms [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines